Mark Houston, MD, MS, FAHA, FASH, DABC; Internist & Cardiovascular Specialist; Director, Hypertension Institute and Vascular Biology
The diagnosis, evaluation, and treatment of dyslipidemia have been misdirected for the past 30-40 years. Dr. Houston presents an evolutionary approach to managing dyslipidemia and dyslipidemia-induced vascular disease by challenging the use of LDL and triglycerides as markers of disease. In this talk he shares new approaches to manage the dyslipidemia epidemic.
Click here for a full list of upcoming MAPS events.